Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Sandler

Showing results (271-280 of 321) with videos related to

Pageof 33
Sort By:
International Journal of Molecular Medicine|April 15, 1999
Morphological and morphometric studies of the splenic antitumor immune response, elicited by liposome-covered soluble p53 kDa antigen, in chemically-induced rat colon cancerH Ben-Hur, E Plonsky, P Gurevich, et al.
Hepatology (Baltimore, Md.)|October 1, 1993
Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): a light and electron microscopic study of the liverP Bioulac-Sage, F Parrot-Roulaud, J P Mazat, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1991
An insight into early reproductive processes through the in vivo model of ovum donationD Navot, P A Bergh, M Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerJ-C Soria, A Mauguen, M Reck, et al.
Investigational New Drugs|May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancerDaniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxisL S Redwine, C B Pert, J D Rone, et al.
Anticancer Research|December 22, 1998
Effects of dietary fiber on the rat intestinal mucosa exposed to low doses of a carcinogenZ Madar, P Gurevich, H Ben-Hur, et al.
Orthopaedic Journal of Sports Medicine|October 20, 2023
Risk Factors for Glenoid Bone Loss in the Setting of Posterior Glenohumeral InstabilityClare K Green, John P Scanaliato, Alexis B Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2008
A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomasLia Gore, Mace L Rothenberg, Cindy L O'Bryant, et al.
Anticancer Research|January 19, 1999
Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in miceH Ben-Hur, A Ben-Meir, Z Hagay, et al.
Pageof 33

Showing results (271-280 of 321) with videos related to

Sort By:
Pageof 33
International Journal of Molecular Medicine|April 15, 1999
Morphological and morphometric studies of the splenic antitumor immune response, elicited by liposome-covered soluble p53 kDa antigen, in chemically-induced rat colon cancerH Ben-Hur, E Plonsky, P Gurevich, et al.
Hepatology (Baltimore, Md.)|October 1, 1993
Fatal neonatal liver failure and mitochondrial cytopathy (oxidative phosphorylation deficiency): a light and electron microscopic study of the liverP Bioulac-Sage, F Parrot-Roulaud, J P Mazat, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1991
An insight into early reproductive processes through the in vivo model of ovum donationD Navot, P A Bergh, M Williams, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 27, 2012
Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancerJ-C Soria, A Mauguen, M Reck, et al.
Investigational New Drugs|May 9, 2008
Phase I trial of pemetrexed plus oxaliplatin administered every other week in patients with metastatic cancerDaniel G Stover, A Craig Lockhart, Jordan D Berlin, et al.
Clinical Immunology (Orlando, Fla.)|October 21, 1999
Peptide T blocks GP120/CCR5 chemokine receptor-mediated chemotaxisL S Redwine, C B Pert, J D Rone, et al.
Anticancer Research|December 22, 1998
Effects of dietary fiber on the rat intestinal mucosa exposed to low doses of a carcinogenZ Madar, P Gurevich, H Ben-Hur, et al.
Orthopaedic Journal of Sports Medicine|October 20, 2023
Risk Factors for Glenoid Bone Loss in the Setting of Posterior Glenohumeral InstabilityClare K Green, John P Scanaliato, Alexis B Sandler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2008
A phase I and pharmacokinetic study of the oral histone deacetylase inhibitor, MS-275, in patients with refractory solid tumors and lymphomasLia Gore, Mace L Rothenberg, Cindy L O'Bryant, et al.
Anticancer Research|January 19, 1999
Tumor-preventive effects of the soluble p53 antigen on chemically-induced skin cancer in miceH Ben-Hur, A Ben-Meir, Z Hagay, et al.
Pageof 33